Penicillamine‐induced myasthenic responses in the guinea pig
- 1 May 1979
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 2 (3) , 186-190
- https://doi.org/10.1002/mus.880020306
Abstract
To study the basis for the myasthenic illness that develops in some patients receiving D-penicillamine (D-P), we measured neuromuscular transmission in D-P-treated guinea pigs. Treated animals manifested edrophonium chloride–repairable decremental responses to 30-Hz nerve stimulation (8.5% ± 1.5%—mean ± SEM; N = 16) compared with the response in saline-treated control animals (−0.3% ± 0.85%, N = 10, p <0.005). Posttetanic phenomena were studied in 5 treated animals; 3 revealed posttetanic exhaustion. Miniature endplate potential (MEPP) amplitudes were significantly reduced in 11 treated animals (0.612 ± 0.016 mV) compared with 6 controls (0.713 ± 0.024 mV, p <0.01). The MEPP frequency appeared reduced in treated animals. Both MEPP amplitude and MEPP frequency correlated with the decrement.This publication has 8 references indexed in Scilit:
- Penicillamine‐induced myasthenia gravis associated with antibodies to acetylcholine receptorNeurology, 1978
- ANTI-ACETYLCHOLINE RECEPTOR ANTIBODIES IN D-PENICILLAMINE-ASSOCIATED MYASTHENIA GRAVISThe Lancet, 1978
- Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodiesThe American Journal of Medicine, 1977
- Penicillamin-induzierte Myasthenie bei chronischer PolyarthritisDeutsche Medizinische Wochenschrift (1946), 1976
- Letter: Pemphigus induced by D-penicillamine.BMJ, 1975
- Myasthenia syndrome during penicillamine treatment.BMJ, 1975
- Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.BMJ, 1975
- Quantal Nature of Synaptic TransmissionPhysiological Reviews, 1966